Market Overview

Kensey Nash Introduces A Novel Biomaterial, Meso BioMatrix Acellular Porcine Peritoneum, For Plastic And Reconstructive Surgery

Kensey Nash Corporation (Nasdaq: KNSY) today announced the achievement of several milestones for its Meso BioMatrix™ surgical mesh including the first clinical implant of the product. The Meso BioMatrix™ product is indicated for use in the United States for implantation to reinforce soft tissue where weakness exists in patients requiring soft tissue repair and reinforcement in plastic and reconstructive surgery. The procedure was performed by Dennis Hammond, M.D. of Partners in Plastic Surgery in Grand Rapids, Michigan. "The Meso BioMatrix™ product offers several advantages for use in plastic and reconstructive surgery including strength with just the right amount of pliability, and easy re-draping around corners and complex contours. It will serve as an excellent adjunct in plastic and reconstructive surgery," commented Dr. Hammond.

Kensey Nash will be exhibiting the Meso BioMatrix™ product May 5th-7th at the American Society of Aesthetic Plastic Surgery Meeting in Vancouver, BC.

Posted-In: News FDA

 

Related Articles (KNSY)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters